Parallax Volatility Advisers, L.P. Natera, Inc. Call Options Transaction History

Parallax Volatility Advisers, L.P.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$37.55 - $62.64 $2.17 Million - $3.63 Million	57,900 New	57,900 $3.63 Million
Q2 2022 Aug 15, 2022	BUY	$28.13 - $44.54 $317,869 - $503,302	11,300 New	11,300 $400,000
Q3 2021 Nov 15, 2021	SELL	$100.17 - $126.36 $6.11 Million - $7.71 Million	-61,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$86.05 - $119.72 $5.25 Million - $7.3 Million	61,000 New	61,000 $6.93 Million

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.